| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |